Learning from Barcelona: Strengthening the London Cancer Hub’s Global Perspective

Over three days in Barcelona, one thing became immediately clear: world-leading life sciences ecosystems don’t happen by chance - they are deliberately designed to work together. Joining a MedCity and Grow London Global trade mission, the London Cancer Hub had the opportunity to learn first-hand from one of Europe’s most coordinated innovation clusters. What followed was a series of conversations and insights that not only showcased Barcelona’s strengths, but also sharpened the questions London must continue to ask as it builds a globally competitive life sciences ecosystem.

Peers from across London’s leading innovation districts, including Paddington Life Sciences, White City and the Knowledge Quarter, engaged with Barcelona’s health and life sciences community. Led by Deputy Mayor Howard Dawber, the mission provided an opportunity to step into a globally recognised ecosystem and learn directly from those shaping it.

Barcelona has established itself as one of Europe’s most coordinated and effective life sciences clusters. Through a series of meetings with researchers, clinicians, founders and system leaders, a consistent theme emerged: strong alignment across partners, and a shared focus on accelerating innovation to patients.

There is a clear sense of purpose across the ecosystem. Clinical, academic and commercial organisations are working in a more integrated way - with streamlined approaches to clinical trials, coordinated patient pathways, and a culture that actively enables collaboration rather than complicates it.

For the London Cancer Hub, these insights are directly relevant.

As one of the UK’s most ambitious life sciences developments, London Cancer Hub brings together world-leading institutions including The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, alongside development and investment partners. Its long-term vision is to create a globally significant centre for oncology research, treatment and innovation.

Delivering that vision requires more than high-quality buildings or infrastructure. It depends on how effectively the ecosystem functions, how easily partners can collaborate, how quickly ideas can move from research to clinical application, and how well the environment supports innovation at every stage.

London already has many of the ingredients required to lead globally: exceptional research capability, a strong clinical base, and access to capital and talent. But missions such as this highlight the importance of continually refining how those elements come together.

The questions for the London Cancer Hub, and for London more broadly, are clear:

How do we create the conditions for more seamless collaboration?

How do we reduce barriers between research, clinical practice and industry?

How do we accelerate the journey from discovery to real-world impact for patients?

These are not abstract considerations. They are central to the development of London Cancer Hub as a connected innovation district.

The value of this trade mission lies not in comparison, but in learning. The openness of colleagues in Barcelona to share their experiences reinforces the importance of international collaboration in tackling global health challenges.

As the London Cancer Hub continues to evolve, these insights will help inform how the district grows - strengthening partnerships, shaping the ecosystem, and ensuring that it delivers meaningful impact both nationally and internationally.

Progress in health innovation does not happen in isolation. It happens when ecosystems learn from one another, challenge assumptions, and move forward together.